JOHNSON KENNETH ERLAND (See Remarks) received a stock award from XERIS PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2020ACC: 0000899243-20-000615
Officer· See Remarks
Since Jan 2019
+286.00
Net shares
Net buyer
$1.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
286.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+286.00
Price / share
$5.99
Trade value
$1.71K
% of position
8.4%
12/31/2019
3.42K→3.71K
Total
Net shares
+286.00
Net value
$1.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2019 | A · Award | +286.00 | $5.99 | $1.71K | 8.4% | 3.42K | 3.71K |
| Total | +286.00 | $1.71K | ||||||
Derivative Transactions0
No derivative transactions reported